SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 461.89 |
| Enterprise Value ($M) | 411.96 |
| Book Value ($M) | 95.74 |
| Book Value / Share | 1.22 |
| Price / Book | 4.82 |
| NCAV ($M) | -64.71 |
| NCAV / Share | -0.83 |
| Price / NCAV | -7.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.34 |
| Current Ratio | 2.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 139.05 |
| Assets | 299.49 |
| Liabilities | 203.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Adage Capital Management, L.P. | 6.77 | ||
| 13G/A | Johnson & Johnson | 8.60 | 0.00 | |
| 13D/A | Perceptive Advisors Llc | 16.40 | 10.96 | |
| 13G/A | Sanofi | 15.80 | 159.65 | |
| 13G/A | Prosight Management, LP | 6.40 | -0.69 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 8.32 | 70.38 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 39,287 | 193,942 | 20.26 | |
| 95,179 | 451,541 | 21.08 | |
| 79,616 | 417,056 | 19.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MCRB – Seres Therapeutics, Inc. | MDGL – Madrigal Pharmaceuticals, Inc. |
| MGNX – MacroGenics, Inc. | MIST – Milestone Pharmaceuticals Inc. |
| MLYS – Mineralys Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io